Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia.
|
Arch Gen Psychiatry
|
2007
|
2.91
|
2
|
The borderline diagnosis I: psychopathology, comorbidity, and personality structure.
|
Biol Psychiatry
|
2002
|
2.75
|
3
|
Characterizing affective instability in borderline personality disorder.
|
Am J Psychiatry
|
2002
|
2.44
|
4
|
Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.
|
Psychopharmacology (Berl)
|
2004
|
2.06
|
5
|
Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia.
|
Am J Psychiatry
|
2011
|
1.93
|
6
|
The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration.
|
Schizophr Bull
|
2006
|
1.88
|
7
|
The borderline diagnosis II: biology, genetics, and clinical course.
|
Biol Psychiatry
|
2002
|
1.81
|
8
|
Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide.
|
Biol Psychiatry
|
2004
|
1.71
|
9
|
Amygdala-prefrontal disconnection in borderline personality disorder.
|
Neuropsychopharmacology
|
2007
|
1.54
|
10
|
Abuse and neglect in childhood: relationship to personality disorder diagnoses.
|
CNS Spectr
|
2003
|
1.38
|
11
|
Fronto-limbic dysfunction in response to facial emotion in borderline personality disorder: an event-related fMRI study.
|
Psychiatry Res
|
2007
|
1.36
|
12
|
Neural correlates of using distancing to regulate emotional responses to social situations.
|
Neuropsychologia
|
2010
|
1.33
|
13
|
Evaluation of behavioral impulsivity and aggression tasks as endophenotypes for borderline personality disorder.
|
J Psychiatr Res
|
2009
|
1.32
|
14
|
Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia.
|
Am J Psychiatry
|
2013
|
1.30
|
15
|
Proposed changes in personality and personality disorder assessment and diagnosis for DSM-5 Part I: Description and rationale.
|
Personal Disord
|
2011
|
1.30
|
16
|
Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia.
|
Schizophr Res
|
2008
|
1.29
|
17
|
The interpersonal dimension of borderline personality disorder: toward a neuropeptide model.
|
Am J Psychiatry
|
2009
|
1.28
|
18
|
Personality disorder types proposed for DSM-5.
|
J Pers Disord
|
2011
|
1.27
|
19
|
Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity.
|
Biol Psychiatry
|
2002
|
1.27
|
20
|
Successful multi-site measurement of antisaccade performance deficits in schizophrenia.
|
Schizophr Res
|
2006
|
1.25
|
21
|
Reduced anterior and posterior cingulate gray matter in borderline personality disorder.
|
Biol Psychiatry
|
2005
|
1.23
|
22
|
Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652.
|
Am J Psychiatry
|
2005
|
1.22
|
23
|
Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression.
|
Arch Gen Psychiatry
|
2002
|
1.22
|
24
|
Neural correlates of the use of psychological distancing to regulate responses to negative social cues: a study of patients with borderline personality disorder.
|
Biol Psychiatry
|
2009
|
1.21
|
25
|
Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands.
|
Biol Psychiatry
|
2008
|
1.19
|
26
|
Neural correlates of emotion processing in borderline personality disorder.
|
Psychiatry Res
|
2009
|
1.18
|
27
|
The relationship of borderline personality disorder to posttraumatic stress disorder and traumatic events.
|
Am J Psychiatry
|
2003
|
1.17
|
28
|
Laboratory induced aggression: a positron emission tomography study of aggressive individuals with borderline personality disorder.
|
Biol Psychiatry
|
2009
|
1.17
|
29
|
Neuropsychological performance in schizotypal personality disorder: importance of working memory.
|
Am J Psychiatry
|
2005
|
1.17
|
30
|
Molecular and genetic evidence for abnormalities in the nodes of Ranvier in schizophrenia.
|
Arch Gen Psychiatry
|
2011
|
1.12
|
31
|
Context-processing deficits in schizotypal personality disorder.
|
J Abnorm Psychol
|
2004
|
1.12
|
32
|
Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia.
|
Schizophr Res
|
2007
|
1.11
|
33
|
Exaggerated affect-modulated startle during unpleasant stimuli in borderline personality disorder.
|
Biol Psychiatry
|
2007
|
1.11
|
34
|
Affective lability and affect intensity as core dimensions of bipolar disorders during euthymic period.
|
Psychiatry Res
|
2008
|
1.10
|
35
|
Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression.
|
Psychopharmacology (Berl)
|
2004
|
1.07
|
36
|
Context processing in schizotypal personality disorder: evidence of specificity of impairment to the schizophrenia spectrum.
|
J Abnorm Psychol
|
2008
|
1.07
|
37
|
Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients.
|
Schizophr Res
|
2008
|
1.07
|
38
|
Potentiated amygdala response to repeated emotional pictures in borderline personality disorder.
|
Biol Psychiatry
|
2012
|
1.06
|
39
|
Frontolimbic structural changes in borderline personality disorder.
|
J Psychiatr Res
|
2007
|
1.05
|
40
|
Cingulate gyrus volume and metabolism in the schizophrenia spectrum.
|
Schizophr Res
|
2004
|
1.05
|
41
|
Deficient attentional modulation of the startle response in patients with schizotypal personality disorder.
|
Am J Psychiatry
|
2003
|
1.04
|
42
|
Differential metabolic rates in prefrontal and temporal Brodmann areas in schizophrenia and schizotypal personality disorder.
|
Schizophr Res
|
2002
|
1.04
|
43
|
Risperidone in the treatment of schizotypal personality disorder.
|
J Clin Psychiatry
|
2003
|
1.03
|
44
|
A system-level transcriptomic analysis of schizophrenia using postmortem brain tissue samples.
|
Arch Gen Psychiatry
|
2012
|
1.02
|
45
|
The role of childhood trauma in differences in affective instability in those with personality disorders.
|
CNS Spectr
|
2003
|
1.00
|
46
|
24-h Monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression.
|
J Psychiatr Res
|
2004
|
1.00
|
47
|
Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia.
|
Schizophr Res
|
2010
|
0.99
|
48
|
Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS).
|
Schizophr Res
|
2011
|
0.97
|
49
|
Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study.
|
Psychophysiology
|
2010
|
0.96
|
50
|
RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia.
|
J Neurochem
|
2003
|
0.96
|
51
|
The effects of guanfacine on context processing abnormalities in schizotypal personality disorder.
|
Biol Psychiatry
|
2006
|
0.95
|
52
|
Frontal-striatal-thalamic mediodorsal nucleus dysfunction in schizophrenia-spectrum patients during sensorimotor gating.
|
Neuroimage
|
2008
|
0.95
|
53
|
Recent advances in the biological study of personality disorders.
|
Psychiatr Clin North Am
|
2008
|
0.93
|
54
|
Smaller superior temporal gyrus volume specificity in schizotypal personality disorder.
|
Schizophr Res
|
2009
|
0.93
|
55
|
Proposed changes in personality and personality disorder assessment and diagnosis for DSM-5 Part II: Clinical application.
|
Personal Disord
|
2011
|
0.92
|
56
|
Neurobiologic function and temperament in subjects with personality disorders.
|
CNS Spectr
|
2003
|
0.92
|
57
|
Impairment in functional capacity as an endophenotype candidate in severe mental illness.
|
Schizophr Bull
|
2011
|
0.91
|
58
|
Dispositional impulsivity in normal and abnormal samples.
|
J Psychiatr Res
|
2006
|
0.91
|
59
|
Pergolide treatment of cognitive deficits associated with schizotypal personality disorder: continued evidence of the importance of the dopamine system in the schizophrenia spectrum.
|
Neuropsychopharmacology
|
2010
|
0.89
|
60
|
Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients.
|
Biol Psychiatry
|
2010
|
0.89
|
61
|
Empathy and alexithymia in borderline personality disorder: clinical and laboratory measures.
|
J Pers Disord
|
2012
|
0.88
|
62
|
Deficient attentional modulation of startle eyeblink is associated with symptom severity in the schizophrenia spectrum.
|
Schizophr Res
|
2007
|
0.88
|
63
|
Sex differences in familiality effects on neurocognitive performance in schizophrenia.
|
Biol Psychiatry
|
2013
|
0.88
|
64
|
Low prolactin response to fenfluramine in impulsive aggression.
|
J Psychiatr Res
|
2004
|
0.88
|
65
|
Childhood trauma and basal cortisol in people with personality disorders.
|
Compr Psychiatry
|
2008
|
0.87
|
66
|
Fine mapping of the 5p13 locus linked to schizophrenia and schizotypal personality disorder in a Puerto Rican family.
|
Psychiatr Genet
|
2005
|
0.86
|
67
|
Convergent findings for abnormalities of the NF-κB signaling pathway in schizophrenia.
|
Neuropsychopharmacology
|
2012
|
0.85
|
68
|
The genetics of functional disability in schizophrenia and bipolar illness: Methods and initial results for VA cooperative study #572.
|
Am J Med Genet B Neuropsychiatr Genet
|
2014
|
0.85
|
69
|
Tryptophan-hydroxylase 2 haplotype association with borderline personality disorder and aggression in a sample of patients with personality disorders and healthy controls.
|
J Psychiatr Res
|
2010
|
0.84
|
70
|
Platelet protein kinase C and brain-derived neurotrophic factor levels in borderline personality disorder patients.
|
Psychiatry Res
|
2012
|
0.84
|
71
|
Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups.
|
Psychiatr Genet
|
2006
|
0.84
|
72
|
Serotonin 2c receptor RNA editing in major depression and suicide.
|
World J Biol Psychiatry
|
2012
|
0.84
|
73
|
The neural correlates of anomalous habituation to negative emotional pictures in borderline and avoidant personality disorder patients.
|
Am J Psychiatry
|
2014
|
0.84
|
74
|
Prefrontal dopamine D1 receptors and working memory in schizotypal personality disorder: a PET study with [¹¹C]NNC112.
|
Psychopharmacology (Berl)
|
2014
|
0.84
|
75
|
Schizoid personality disorder.
|
J Pers Disord
|
2012
|
0.83
|
76
|
The neurobiology of empathy in borderline personality disorder.
|
Curr Psychiatry Rep
|
2013
|
0.83
|
77
|
Cingulate and temporal lobe fractional anisotropy in schizotypal personality disorder.
|
Neuroimage
|
2011
|
0.82
|
78
|
Functional MRI of visuospatial working memory in schizotypal personality disorder: a region-of-interest analysis.
|
Psychol Med
|
2005
|
0.82
|
79
|
Anterior and posterior cingulate cortex volume in healthy adults: effects of aging and gender differences.
|
Brain Res
|
2011
|
0.82
|
80
|
CACNA1C as a risk factor for schizotypal personality disorder and schizotypy in healthy individuals.
|
Psychiatry Res
|
2012
|
0.82
|
81
|
Anterior limb of the internal capsule in schizotypal personality disorder: fiber-tract counting, volume, and anisotropy.
|
Schizophr Res
|
2012
|
0.81
|
82
|
Dorso- and ventro-lateral prefrontal volume and spatial working memory in schizotypal personality disorder.
|
Behav Brain Res
|
2010
|
0.81
|
83
|
Irritable assault and variation in the COMT gene.
|
Psychiatr Genet
|
2007
|
0.81
|
84
|
Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizotypal personality disorder.
|
Schizophr Res
|
2004
|
0.81
|
85
|
Dual-task information processing in schizotypal personality disorder: evidence of impaired processing capacity.
|
Neuropsychology
|
2006
|
0.81
|
86
|
Reduced processing resource availability in schizotypal personality disorder: evidence from a dual-task CPT study.
|
J Clin Exp Neuropsychol
|
2003
|
0.80
|
87
|
Striatal activity in borderline personality disorder with comorbid intermittent explosive disorder: sex differences.
|
J Psychiatr Res
|
2012
|
0.80
|
88
|
Functional outcomes, functional capacity, and cognitive impairment in schizotypal personality disorder.
|
Schizophr Res
|
2013
|
0.79
|
89
|
Schizotypal personality disorder: a current review.
|
Curr Psychiatry Rep
|
2014
|
0.79
|
90
|
Psychometric properties of a short form of the Affective Lability Scale (ALS-18).
|
Pers Individ Dif
|
2010
|
0.79
|
91
|
Neurocognitive performance in family-based and case-control studies of schizophrenia.
|
Schizophr Res
|
2015
|
0.79
|
92
|
Catechol-O-methyltransferase Val158Met genotype in healthy and personality disorder individuals: Preliminary results from an examination of cognitive tests hypothetically differentially sensitive to dopamine functions.
|
Neuropsychiatr Dis Treat
|
2007
|
0.79
|
93
|
Visual-spatial learning and memory in schizotypal personality disorder: continued evidence for the importance of working memory in the schizophrenia spectrum.
|
Arch Clin Neuropsychol
|
2006
|
0.78
|
94
|
Genetic variations in the ADAMTS12 gene are associated with schizophrenia in Puerto Rican patients of Spanish descent.
|
Neuromolecular Med
|
2012
|
0.78
|
95
|
Deficient visual sensitivity in schizotypal personality disorder.
|
Schizophr Res
|
2010
|
0.78
|
96
|
Empathic accuracy and cognition in schizotypal personality disorder.
|
Psychiatry Res
|
2013
|
0.78
|
97
|
Eye tracking performance and the boundaries of the schizophrenia spectrum.
|
Psychiatry Res
|
2010
|
0.77
|
98
|
Growth hormone response to guanfacine in boys with attention deficit hyperactivity disorder: a preliminary study.
|
J Child Adolesc Psychopharmacol
|
2003
|
0.77
|
99
|
Biochemical endophenotypes in personality disorders.
|
Methods Mol Med
|
2003
|
0.77
|
100
|
Larger putamen size in antipsychotic-naïve individuals with schizotypal personality disorder.
|
Schizophr Res
|
2012
|
0.77
|
101
|
Hypermentalization in adolescents with borderline personality traits: extending the conceptual framework to younger ages.
|
J Am Acad Child Adolesc Psychiatry
|
2011
|
0.77
|
102
|
Conflict of interest-- an issue for every psychiatrist.
|
Am J Psychiatry
|
2009
|
0.77
|
103
|
Joint Effect of Childhood Abuse and Family History of Major Depressive Disorder on Rates of PTSD in People with Personality Disorders.
|
Depress Res Treat
|
2012
|
0.77
|
104
|
The effects of risperidone on the cognitive performance of individuals with schizotypal personality disorder.
|
J Clin Psychopharmacol
|
2009
|
0.76
|
105
|
Blunted hormone responses to Ipsapirone are associated with trait impulsivity in personality disorder patients.
|
Neuropsychopharmacology
|
2006
|
0.76
|
106
|
Vocational functioning in schizotypal and paranoid personality disorders.
|
Psychiatry Res
|
2013
|
0.76
|
107
|
Schizotypal personality disorder.
|
J Pers Disord
|
2012
|
0.76
|
108
|
Evidence-based pharmacotherapy for personality disorders.
|
Int J Neuropsychopharmacol
|
2011
|
0.76
|
109
|
"Late-onset" borderline personality disorder: a life unraveling.
|
Harv Rev Psychiatry
|
2002
|
0.76
|
110
|
Paranoid personality disorder.
|
J Pers Disord
|
2012
|
0.75
|
111
|
No link of serotonin 2C receptor editing to serotonin transporter genotype.
|
Neuroreport
|
2010
|
0.75
|
112
|
It is time to take a stand for medical research and against terrorism targeting medical scientists.
|
Biol Psychiatry
|
2008
|
0.75
|
113
|
Erratum: The relationship between dopamine receptor D1 and cognitive performance.
|
NPJ Schizophr
|
2015
|
0.75
|
114
|
Personality disorders.
|
Handb Clin Neurol
|
2012
|
0.75
|
115
|
Efficacy of open-label venlafaxine in subjects with major depressive disorder: associations with neuroendocrine response to serotonergic and noradrenergic probes.
|
Psychiatry Res
|
2004
|
0.75
|